Federated Hermes, Inc. Cara Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

  • $42.5 Billion
  • Q1 2024

A detailed history of Federated Hermes, Inc. transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 12,272 shares of CARA stock, worth $4,049. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,272
Previous 831,849 98.52%
Holding current value
$4,049
Previous $615,000 98.21%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$0.52 - $1.05 $426,180 - $860,555
-819,577 Reduced 98.52%
12,272 $11,000
Q4 2023

Jan 31, 2024
BUY
$0.6 - $1.65 $17,019 - $46,802
28,365 Added 3.53%
831,849 $615,000
Q3 2023

Nov 13, 2023
SELL
$1.67 - $3.33 $10,771 - $21,478
-6,450 Reduced 0.8%
803,484 $1.35 Million
Q2 2023

Aug 14, 2023
BUY
$2.83 - $4.94 $1.77 Million - $3.09 Million
625,585 Added 339.35%
809,934 $2.29 Million
Q1 2023

May 08, 2023
BUY
$4.89 - $12.27 $901,466 - $2.26 Million
184,349 New
184,349 $905,000
Q2 2022

Aug 15, 2022
SELL
$7.45 - $13.84 $20,800 - $38,641
-2,792 Reduced 46.46%
3,217 $29,000
Q1 2022

May 13, 2022
BUY
$9.94 - $12.65 $12,941 - $16,470
1,302 Added 27.66%
6,009 $73,000
Q4 2021

Feb 14, 2022
SELL
$11.99 - $18.14 $76,843 - $116,259
-6,409 Reduced 57.66%
4,707 $57,000
Q3 2021

Nov 15, 2021
SELL
$11.55 - $16.06 $20,524 - $28,538
-1,777 Reduced 13.78%
11,116 $172,000
Q2 2021

Aug 16, 2021
BUY
$12.38 - $29.19 $159,615 - $376,346
12,893 New
12,893 $184,000
Q4 2019

Feb 14, 2020
SELL
$16.11 - $25.98 $1.7 Million - $2.74 Million
-105,276 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$18.28 - $26.91 $1.92 Million - $2.83 Million
105,066 Added 50031.43%
105,276 $1.92 Million
Q2 2019

Aug 14, 2019
BUY
$17.68 - $21.57 $3,712 - $4,529
210 New
210 $5,000
Q1 2019

May 10, 2019
SELL
$14.41 - $19.64 $801,181 - $1.09 Million
-55,599 Closed
0 $0
Q4 2018

Feb 13, 2019
SELL
$12.45 - $23.47 $470,821 - $887,564
-37,817 Reduced 40.48%
55,599 $722,000
Q3 2018

Nov 13, 2018
BUY
$17.57 - $23.95 $1.64 Million - $2.23 Million
93,238 Added 52380.9%
93,416 $2.24 Million
Q2 2018

Aug 10, 2018
BUY
$11.6 - $19.27 $2,064 - $3,430
178 New
178 $3,000
Q1 2018

May 09, 2018
SELL
$11.77 - $16.08 $459,571 - $627,859
-39,046 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$11.86 - $14.08 $7,697 - $9,137
-649 Reduced 1.63%
39,046 $0
Q3 2017

Nov 13, 2017
BUY
$12.6 - $16.34 $500,157 - $648,616
39,695
39,695 $543,000

Others Institutions Holding CARA

# of Institutions
102
Shares Held
21.5M
Call Options Held
50K
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $17.7M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email